Dow Down 0.66% Nasdaq Down 1.08%

Cytori Therapeutics, Inc. (CYTX)

-NasdaqGM
0.68 Up 0.02(3.03%) 11:47AM EDT - Nasdaq Real Time Price
Prev Close:0.66
Open:0.66
Bid:0.68 x 10900
Ask:0.69 x 1300
1y Target Est:5.13
Beta:2.25
Next Earnings Date:N/A
Day's Range:0.65 - 0.69
52wk Range:0.64 - 3.93
Volume:218,151
Avg Vol (3m):499,703
Market Cap:54.09M
P/E (ttm):N/A
EPS (ttm):-0.52
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for CYTX

Comparison

Symbol% ChgMkt Cap
CYTXUp 3.03%54.09M
ASTMDown 2.62%21.89M
BAXDown 0.84%38.41B
OSIRDown 0.16%423.03M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):5.90
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.42
Quarterly EPS Est (Sep-14) :-0.07
Mean Recommendation*:2.3
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Cytori Therapeutics, Inc., a cell therapy company, develops cell therapies based on autologous adipose-derived regenerative cells (ADRCs) to treat cardiovascular disease and other medical conditions. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback